249 related articles for article (PubMed ID: 29390288)
1. Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: Meta-analysis of randomized controlled trials.
Lai D; Zhao F; Jalal N; Zheng Y
Medicine (Baltimore); 2017 Dec; 96(50):e8955. PubMed ID: 29390288
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.
Mirian C; Ovesen T
JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):421-428. PubMed ID: 32163109
[TBL] [Abstract][Full Text] [Related]
3. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis.
Gao Y; Liu D
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3699-3711. PubMed ID: 27071771
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic corticosteroid injection as a first-line treatment of the patients with idiopathic sudden sensorineural hearing loss compared to systemic steroid: A systematic review and meta-analysis.
Mirsalehi M; Ghajarzadeh M; Farhadi M; Akbarnejad Z; Ahmadi S; Salem MM
Am J Otolaryngol; 2022; 43(5):103505. PubMed ID: 35714500
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials.
Li J; Ding L
Ann Pharmacother; 2020 Oct; 54(10):949-957. PubMed ID: 32126823
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 Pandemic.
Tsuda T; Hanada Y; Wada K; Fujiwara E; Takeda K; Nishimura H
Ear Nose Throat J; 2023 Dec; 102(12):772-779. PubMed ID: 34247535
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high dose systemic versus combined (systemic and intratympanic) corticosteroid therapy in idiopathic sudden sensorineural hearing loss: A prospective randomized trial and risk factor analysis.
Kovács M; Uzsaly J; Bodzai G; Pap I; Lippai B; Dergez T; Németh A; Gerlinger I; Szanyi I; Bakó P
Am J Otolaryngol; 2024; 45(1):104099. PubMed ID: 37948820
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Different Treatment Protocols Using Systemic and Intratympanic Steroids with and without Hyperbaric Oxygen Therapy in Patients with Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Controlled Trial.
Cho I; Lee HM; Choi SW; Kong SK; Lee IW; Goh EK; Oh SJ
Audiol Neurootol; 2018; 23(4):199-207. PubMed ID: 30380530
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic dexamethasone for managing pregnant women with sudden hearing loss.
Fu Y; Jing J; Ren T; Zhao H
J Int Med Res; 2019 Jan; 47(1):377-382. PubMed ID: 30328358
[TBL] [Abstract][Full Text] [Related]
10. Management of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) Intratympanic Platelet-Rich Plasma (PRP) Versus Intratympanic Steroid Injections: A Cross-Sectional Study.
Shawky M
Otolaryngol Pol; 2024 Jun; 78(3):1-6. PubMed ID: 38808642
[TBL] [Abstract][Full Text] [Related]
11. Vestibular prognosis in idiopathic sudden sensorineural hearing loss with vestibular dysfunction treated with oral or intratympanic glucocorticoids: a protocol for randomized controlled trial.
Hao W; Zhao L; Yu H; Li H
Trials; 2020 Jul; 21(1):669. PubMed ID: 32698830
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
13. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss].
Sun RX; Zhao Y; Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):972-977. PubMed ID: 29771066
[No Abstract] [Full Text] [Related]
14. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss.
Baysal E; Tunç O; Baglam T; Durucu C; Oz A; Karatas ZA; Polat M; Celenk F; Mumbuc S; Kanlikama M
J Craniofac Surg; 2013 Mar; 24(2):432-4. PubMed ID: 23524709
[TBL] [Abstract][Full Text] [Related]
15. A comparison between systemic and intratympanic steroid therapies as initial therapy for idiopathic sudden sensorineural hearing loss: a meta-analysis.
Qiang Q; Wu X; Yang T; Yang C; Sun H
Acta Otolaryngol; 2017 Jun; 137(6):598-605. PubMed ID: 27921520
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and network meta-analysis of existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss.
Ahmadzai N; Kilty S; Cheng W; Esmaeilisaraji L; Wolfe D; Bonaparte JP; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Moher D; Hutton B
PLoS One; 2019; 14(9):e0221713. PubMed ID: 31498809
[TBL] [Abstract][Full Text] [Related]
17. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone.
Hobson CE; Alexander TH; Harris JP
Curr Opin Otolaryngol Head Neck Surg; 2016 Oct; 24(5):407-12. PubMed ID: 27379547
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic steroids for combined treatment of idiopathic sudden hearing loss: when is it too late?
Amarillo E; Navarro A; Hernández-García E; Plaza G
Acta Otolaryngol; 2019 Jul; 139(7):632-635. PubMed ID: 31124732
[No Abstract] [Full Text] [Related]
19. Combined Intratympanic and Systemic Use of Steroids as a First-Line Treatment for Sudden Sensorineural Hearing Loss: A Meta-Analysis of Randomized, Controlled Trials.
Han X; Yin X; Du X; Sun C
Otol Neurotol; 2017 Apr; 38(4):487-495. PubMed ID: 28207624
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic and systemic steroids for sudden hearing loss.
Koltsidopoulos P; Bibas A; Sismanis A; Tzonou A; Seggas I
Otol Neurotol; 2013 Jun; 34(4):771-6. PubMed ID: 23652330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
